30 C
Vientiane
Sunday, May 4, 2025
spot_img
Home Blog Page 30

SecAI Debuts at RSA 2025, Redefining Threat Investigation with AI

By fusing agentic AI and contextual threat intelligence, SecAI transforms investigation from a bottleneck into a force multiplier.

SAN FRANCISCO, April 30, 2025 /PRNewswire/ — SecAI, an AI-enriched threat intelligence company, made its official debut today at RSA Conference 2025 in San Francisco, marking the company’s first public appearance on the global cybersecurity stage. At the event, the SecAI team is showcasing the latest version of its platform to security professionals from around the world.

The updated SecAI Investigator platform is purpose-built to solve one of cybersecurity’s most stubborn challenges: efficient threat investigation. It tackles this by combining two key innovations. First, it delivers curated, high-fidelity threat intelligence, which includes clear verdicts, multi-dimensional labels, and rich context like historical attack behavior through a unified interface. Second, it’s designed from the ground up with an AI-native architecture. The platform leverages advanced AI techniques not only for natural language interaction, but for deep information integration, contextual security reasoning, and suggest remediation options.

SecAI Booth At RSA Conference 2025, N-6570
SecAI Booth At RSA Conference 2025, N-6570

“We believe the future of cybersecurity lies in intelligent systems that can think and adapt like seasoned analysts,” said Chase Lee, Managing Director at SecAI. “Threat investigation has remained one of the most human-intensive parts of the SOC, but it doesn’t have to be. By combining deep threat intelligence with agentic AI, we’re not just accelerating investigations—we’re reshaping what’s possible in cyber defense. This is about giving security teams superhuman capabilities to meet the scale and speed of modern threats.”

In the security operations lifecycle—typically divided into detection, investigation, and response—automation has advanced detection and response dramatically over the past decade. But investigation remains a critical bottlenecks, often consuming over 70% of analysts’ time. SecAI believes that effective investigation depends on two essential capabilities: accurately gathering and organizing relevant information, and making sound, timely judgments. The main blockers today are:

  • A lack of timely, comprehensive threat intelligence
  • Ineffective methods for connecting data points to practical workflows

SecAI Investigator addresses both. By streamlining the investigation process, the platform enables analysts to rapidly evaluate the nature and relevance of IPs, domains, and threat actors, dive deep into logs and alerts, and make faster, more confident decisions.

Looking ahead, SecAI plans to roll out API and threat intelligence feed integrations, allowing customers to embed SecAI’s contextual threat intelligence directly into their existing systems and workflows. This will enable real-time enrichment, faster responses, and more scalable intelligence-driven operations across teams.

Visit SecAI Investigator to explore the platform or connect with the SecAI team at RSA Conference 2025 at Booth 6570 for live demos and early access.

About SecAI

SecAI is an AI-native cybersecurity company specializing in threat detection, investigation, and response. By deeply analyzing adversary tactics, techniques, and procedures (TTPs) and fusing advanced generative AI with rich, contextual threat intelligence, SecAI delivers smarter, faster, and more effective solutions for modern security teams. Our mission is to transform cybersecurity operations by empowering analysts with intelligent systems that scale expertise and accelerate decision-making.

Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar

  • Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations
  • Henlius to receive $31 million upfront, and up to $270 million in milestones

SHANGHAI, April 29, 2025 /PRNewswire/ — On April 29, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) announced a licensing agreement with Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines, granting exclusive commercialization rights for its self-developed ipilimumab biosimilar HLX13 in the United States, 42 European countries and regions, Japan, Canada, and Australia.

Under the agreement, Henlius will be responsible for development, manufacturing and commercial supply of HLX13, and is eligible to receive up to a total of $301 million, including a $31 million upfront and additional milestone payments. As the global leader in generic and biosimilar medicines, Sandoz is committed to its purpose of “pioneering access for patients” and has benefited over 900 million patients worldwide with approximately 1,300 products. This collaboration will leverage Sandoz’s established global network and commercialization expertise to accelerate the accessibility of HLX13 in mainstream biopharma markets.

“At Henlius, we remain deeply committed to delivering high-quality biologics to patients around the world,” said Dr. Jason Zhu, Executive Director and Chief Executive Officer of Henlius. “Our collaboration with Sandoz marks another important step toward enhancing the global accessibility of our therapies. We believe that putting patients at the core of our globalization strategy is key to fulfilling our vision of ‘Developed in China, Access for the World.'”

“We’re excited to join forces with Sandoz,” said Ping Cao, Chief Business Officer and Senior Vice President of Henlius. “By combining Henlius’ proven strengths in biologics R&D and manufacturing with extensive global reach and commercialization expertise of Sandoz, we aim to accelerate the worldwide expansion of HLX13 and bring advanced treatment options to more patients across key markets.”

HLX13 is a key component of Henlius’ self-developed biosimilar pipeline. Its reference product, Yervoy®, the world’s first CTLA-4 inhibitor, has been approved in various countries and regions in combination with nivolumab for the treatment of melanoma and hepatocellular carcinoma, among other indications. Henlius has established an integrated global platform for R&D, regulatory registration, and clinical operations, backed by a manufacturing and quality management system that meets global regulatory standards. The company has successfully launched four products in markets beyond China. Henlius is committed to advancing the global development of HLX13 and working with partners to provide more high-quality, affordable treatment options for patients worldwide.

* Yervoy® is a registered trademark of Bristol-Myers Squibb (US)

About Henlius

Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 6 products have been launched in China, 4 have been approved for marketing in overseas markets, and 5 marketing applications have been accepted for review in China, the U.S. and the EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing and commercialization. It has established global innovation centre and Shanghai-based commercial manufacturing facilities certificated by China, the EU and U.S. GMP.

Henlius has pro-actively built a diversified and high-quality product pipeline covering about 50 molecules and has continued to explore immuno-oncology combination therapies with proprietary HANSIZHUANG (anti-PD-1 mAb) as the backbone. To date, the company’s launched products include HANLIKANG (rituximab), the first China-developed biosimilar, HANQUYOU (trastuzumab, trade name: HERCESSI™ in the U.S., Zercepac® in Europe), a China-developed mAb biosimilar approved in China, Europe and U.S., HANDAYUAN (adalimumab), HANBEITAI (bevacizumab), HANSIZHUANG (serplulimab, trade name: Hetronifly® in Europe), the world’s first anti-PD-1 mAb for the first-line treatment of SCLC, and HANNAIJIA (neratinib). What’s more, Henlius has conducted over 30 clinical studies for 19 products, expanding its presence in major markets as well as emerging markets.

 

Arkieva Announces Strategic Growth Investment from Banneker Partners

WILMINGTON, Del., April 29, 2025 /PRNewswire/ — Arkieva, a leading provider of supply chain planning software solutions, today announced a significant growth investment from Banneker Partners (Banneker). This strategic partnership marks a pivotal moment in Arkieva’s 30-year journey and is set to accelerate the company’s growth trajectory.

“We are thrilled to partner with Banneker Partners,” said Harpal Singh, CEO of Arkieva. “Their expertise in scaling software businesses and deep understanding of the supply chain industry will be invaluable as we enter our next phase of growth. This investment will enable us to enhance our innovative solutions and better serve our global customers.”

Arkieva has established itself as a category-leading supply chain planning software provider, trusted by global manufacturers and distributors to manage $110 billion in revenue planning. The company’s modern Software as a Service (SaaS) solutions offer unrivaled digital twin and autonomous control tower capabilities, addressing critical issues such as poor visibility, shifting labor inputs, global instability and sustainability concerns.

“We are pleased to partner with Arkieva and support their mission to drive innovation in the process manufacturing sector,” said Kenneth Frank, Partner at Banneker. “This investment demonstrates Banneker’s commitment to fostering innovation and supporting companies that are shaping the future of supply chain technology.”

The investment from Banneker Partners aims to equip Arkieva for a new phase of growth, enabling the company to sustain its leading position and address evolving market demand.

“Arkieva is a unique software company that serves the needs of the process manufacturing industry and provides clear return on investment,” commented Harjot Sachdeva, Operating Partner at Banneker. “We are committed to supporting Arkieva as they continue to deliver exceptional value to their customers and drive industry innovation.”

This partnership is expected to:

  • Facilitate inorganic growth and accelerate Arkieva’s current trajectory
  • Leverage Banneker’s proven track record in scaling excellence across industry verticals
  • Implement a robust value creation plan harnessing deep expertise

Dhiran Singh, Executive VP of Arkieva, commented, “Joining forces with Banneker Partners is a natural step in our mission to empower businesses with smarter, more agile planning solutions. By combining our strengths, we can offer manufacturers an unparalleled suite of tools that integrates planning, scheduling and execution, ultimately driving greater business performance.”

“Brown Gibbons Lang & Company (BGL) was pleased to advise Arkieva in securing a strategic partnership with Banneker Partners. This collaboration brings together Banneker’s operating experience and extensive track record in supply chain and manufacturing with Arkieva’s leading planning and scheduling software solution for the process industry,” said Scott Mattson, Head of BGL’s Technology investment banking team. “This new partnership will help Arkieva accelerate product innovation and drive greater value to their customers,” added Michael Magruder, Managing Director of BGL’s Supply Chain Software investment banking team.

About Arkieva

For more than 30 years, Arkieva has helped global enterprises drive business transformation through improved supply chain processes. The company’s demand, inventory, supply and integrated business planning solutions increase growth and profits, and provide the agility and efficiency needed to respond to an ever-changing supply chain environment. Our approach combines strategic consultation, powerful software technologies and iterative implementation to deliver scalable solutions tailored to the complexities of each customer’s operations. Arkieva’s culture of innovation keeps customers like Wells Enterprises, Bakelite Synthetics and Momentive Performance Materials at the forefront of supply chain planning.

Arkieva is headquartered in Wilmington, Delaware USA with offices in Antwerp, Belgium and Mangalore, India. For more information, visit www.arkieva.com.

CONNECT WITH ARKIEVA

Arkieva Media Contact:

Kristan Theile
Director of Marketing, Arkieva
513-376-0300
ktheile@arkieva.com 

About Banneker Partners

Banneker Partners invests in growing, mission-critical enterprise software businesses to drive sustainable long-term value. They take a partnership approach to support founders and management teams, implementing proven best practices and making strategic investments to enhance customer value.

About Brown Gibbons Lang & Company

Brown Gibbons Lang & Company (BGL) is a leading independent investment bank focused on the global middle market. The firm advises private and public corporations and private equity groups on mergers and acquisitions, divestitures, capital markets, financial restructurings, valuations and opinions, real estate and other strategic matters. BGL has investment banking offices in Boston, Chicago, Cleveland, Los Angeles and New York.

 

Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilar

  • Partnership covers North America, Europe, Japan, and Australia to accelerate global access of HLX13 in immuno-oncology combinations
  • Henlius to receive $31 million upfront, and up to $270 million in milestones

SHANGHAI, April 29, 2025 /PRNewswire/ — On April 29, 2025, Shanghai Henlius Biotech, Inc. (2696.HK) announced a licensing agreement with Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines, granting exclusive commercialization rights for its self-developed ipilimumab biosimilar HLX13 in the United States, 42 European countries and regions, Japan, Canada, and Australia.

Under the agreement, Henlius will be responsible for development, manufacturing and commercial supply of HLX13, and is eligible to receive up to a total of $301 million, including a $31 million upfront and additional milestone payments.  As the global leader in generic and biosimilar medicines, Sandoz is committed to its purpose of “pioneering access for patients” and has benefited over 900 million patients worldwide with approximately 1,300 products. This collaboration will leverage Sandoz’s established global network and commercialization expertise to accelerate the accessibility of HLX13 in mainstream biopharma markets.

HLX13 is a key component of Henlius’ self-developed biosimilar pipeline. Its reference product, Yervoy®, the world’s first CTLA-4 inhibitor, has been approved in various countries and regions in combination with nivolumab for the treatment of melanoma and hepatocellular carcinoma, among other indications. Henlius has established an integrated global platform for R&D, regulatory registration, and clinical operations, backed by a manufacturing and quality management system that meets global regulatory standards. The company has successfully launched four products in markets beyond China. Henlius is committed to advancing the global development of HLX13 and working with partners to provide more high-quality, affordable treatment options for patients worldwide.

 

 

Jollibee Group recognized anew with Gallup Exceptional Workplace Award

Jollibee Group remains the sole Philippine-based company to be recognized by the prestigious award


MANILA, PHILIPPINES – Media OutReach Newswire – 29 April 2025 – The Jollibee Group, one of the world’s fastest-growing restaurant companies, has once again been recognized for its commitment to fostering a joyful workplace culture. For the fourth time, the company has received the Gallup Exceptional Workplace Award (GEWA)—a prestigious global recognition given to organizations that set the benchmark for employee engagement and performance.

Jollibee Group remains the sole Philippine-based company to be recognized by the prestigious award
Jollibee Group remains the sole Philippine-based company to be recognized by the prestigious award

Jollibee Group remains the only Philippine-based company to receive this honor, standing alongside a select group of organizations worldwide that have successfully embedded employee engagement as a core driver of their business strategy.

“Our continued recognition as an employer of choice affirms what we’ve always believed –that our people are the driving force of our success,” said Ernesto Tanmantiong, Jollibee Group’s Global President and Chief Executive Officer. “This award is a testament to the passion and dedication of our teams worldwide who bring joy to our customers and one another every day.”

“We remain committed to nurturing a workplace culture where our people can thrive, grow, and find purpose in what they do,” added Tanmantiong.

“Congratulations to this year’s Gallup Exceptional Workplace Award winners for setting the standard for a thriving workplace. By prioritizing both people and performance, you are shaping the future of work and proving that exceptional workplaces drive real results,” said Jon Clifton, Gallup’s chief executive officer.

Recognized Employer of Choice

This latest recognition comes on the heels of the company’s recognition as 2024’s “Employer of the Year” by the People Management Association (PMAP)—the premier and largest association of people managers in the Philippines. This comes after a rigorous competitive process involving other major companies in the country.

Jollibee Group’s Global Chief Human Resources Officer, Arsenio “Archie” Sabado, was also recognized as People Manager of the Year by PMAP, recognizing his role in shaping the company’s joyful culture.

The Jollibee Group was also included in TIME Magazine’s list of the World’s Best Companies for 2024 and made the FORTUNE 500’s inaugural Southeast Asia list.

The company employs over 31,000 people worldwide, with a footprint spanning 9,700 stores in 32 countries across its 19 brands. To learn more about the Jollibee Group, visit www.jollibeegroup.com. To learn more about the Gallup Exceptional Workplace Awards, visit https://www.gallup.com/workplace/657323/announcing-2025-gallup-exceptional-workplace-award-winners.aspx.

Hashtag: #JollibeeGroup

The issuer is solely responsible for the content of this announcement.

About Jollibee Group

Jollibee Foods Corporation (JFC), also known as the Jollibee Group, is one of the world’s fastest-growing restaurant companies, with a mission to deliver great-tasting food, bringing the joy of eating through its 19 brands with over 9,700 stores across 32 countries.

The Jollibee Group’s portfolio includes nine wholly owned brands (Jollibee, Chowking, Greenwich, Red Ribbon, Mang Inasal, Yonghe King, Hong Zhuang Yuan, Smashburger and Tim Ho Wan), five franchised brands (Burger King, Panda Express, Yoshinoya, Common Man Coffee Roasters, and Tiong Bahru Bakery in the Philippines), and ownership stakes in other key brands like The Coffee Bean and Tea Leaf (80%), Compose Coffee (70%), SuperFoods Group that operates Highlands Coffee (60%), and bubble tea brand Milksha (51%). The Company also has membership interests in Tortazo, LLC, along with Chef Rick Bayless, for Tortazo in the U.S. and has recently invested in Botrista, a leader in beverage technology.

The Jollibee Group’s global sustainability agenda, Joy for Tomorrow, underscores its commitment to sustainable business practices across food safety, employee welfare, community support, good governance, and environmental responsibility, among others. These focus areas are aligned with the United Nations Sustainable Development Goals (UN SDGs).

The Jollibee Group has been recognized as the Philippines’ Most Admired Company by the Asian Wall Street Journal, named one of Asia’s Fab 50 Companies, and listed among Forbes’ World’s Best Employers and Top Female-Friendly Companies. The Company is also a three-time Gallup Exceptional Workplace Award recipient and featured in TIME’s World’s Best Companies and Fortune’s Southeast Asia 500 List.

To learn more about Jollibee Group, visit

TERREPOWER, formerly BBB Industries, Releases 2024 Corporate Sustainability Report, Showcasing Progress Toward Circular Economy Leadership

DAPHNE, Ala., April 29, 2025 /PRNewswire/ — TERREPOWER, a leader in sustainable manufacturing serving the automotive and industrial markets, announced the release of its 2024 Corporate Sustainability Report. The report highlights the company’s significant progress in reducing its environmental impact and accelerating the shift to a circular economy.

In 2024, TERREPOWER sustainably manufactured over 17 million parts, avoided more than 162,000 metric tons of carbon emissions, and kept 166 million pounds of waste from entering landfills. The report highlights major achievements including a 22% reduction in Scope 1 emissions and a new on-site wastewater treatment facility in Mexico that has processed over 6 million liters of water since February.

“Sustainability is at the heart of how we operate, innovate, and grow,” said Mark Nugent, Chief Sustainability Officer at TERREPOWER. “From emissions reductions to renewable energy investments and community partnerships, our focus remains on driving measurable impact and setting new standards for sustainable manufacturing across our industry.”

The report also underscores the company’s commitment to empowering its employees and communities. Through various initiatives, TERREPOWER is embedding sustainability into its culture at every level.

“Our growth and environmental stewardship go hand-in-hand,” said Duncan Gillis, CEO of TERREPOWER. “This year’s achievements reflect our long-term commitment to leading the transition to a more circular and resilient economy, backed by data, innovation, and the passion of our global team.”

The full 2024 Corporate Sustainability Report is now available online at: terrepower.com/sustainability

About TERREPOWER
TERREPOWER, formerly BBB Industries, LLC, is a global leader in sustainable manufacturing, specializing in providing high-quality, reliable products to the automotive and industrial markets.  With an extensive footprint and operations throughout North America and Europe, TERREPOWER sustainably manufactures and supplies an assortment of nondiscretionary repair parts across more than 90 countries. Founded in 1987, TERREPOWER has a legacy of innovation and a commitment to advancing the circular economy and extending product lifecycles.

www.terrepower.com

Huayan Robotics to Make Official Debut at FABTECH Mexico 2025

MONTERREY, Mexico, April 29, 2025 /PRNewswire/ — Huayan Robotics, formerly known as Han’s Robot, will make its official debut at FABTECH Mexico 2025, held from May 6–8 at Booth 1937. As North America’s premier metalworking and manufacturing exhibition, FABTECH offers the ideal platform for Huayan Robotics to unveil its latest innovations in industrial automation.

Visitors to Booth 1937 can explore Huayan Robotics’ advanced robotics solutions, including the Elfin and Elfin-Pro Collaborative Robots and the S-Heavy Payload Robots—each designed to push the boundaries of efficiency, flexibility, and performance on the factory floor.

This marks the company’s first major event appearance since its official rebranding on March 28, 2025. More than a name change, the transition to Huayan Robotics—“Leading in the Era of Robotics, Scaling Peaks of Technology”—represents the next chapter in a journey that began with Han’s Laser, advanced through the Han’s Robotics Research Institute, and matured into global innovation leadership as Han’s Robot.

“As Huayan Robotics, we’re not only continuing our legacy of pioneering automation—we’re setting new standards for collaborative and intelligent robotics,” said a company spokesperson.

Featured Solutions at FABTECH Mexico 2025:

  • E12-Pro Collaborative Robot: With a 1.8-meter arm reach and 12kg payload capacity, the E12-Pro delivers versatile, high-performance automation across a wide range of applications, such as assembly, picking, welding, grinding, spraying, and various other applications—without the need for auxiliary lifts or rails. It’s an ideal solution for manufacturers seeking compact, agile systems.
  • S35 Heavy Payload Robot: Designed for high-speed palletizing, the S35 boasts a 35kg payload and 1800mm reach—matching the capabilities of traditional industrial robots. It delivers 8–13 palletizing cycles per minute, making it 38% faster than conventional systems and the perfect turnkey solution for demanding workstations.

Join us at Booth 1937 to discover how Huayan Robotics is shaping the future of industrial automation. Explore our flagship technologies, meet our expert team, and discuss potential collaboration opportunities.

  • Booth: no.1937
  • Date: May 6–8, 2025
  • Location: Monterrey, Mexico

Huayan Robotics at FABTECH Mexico 2025
Huayan Robotics at FABTECH Mexico 2025

About Huayan Robotics

Huayan Robotics is a National High-Tech and “Little Giant” Enterprise in China. Formerly Han’s Robot, the company specializes in intelligent collaborative robotics for industries including manufacturing, healthcare, logistics, education, and beyond.

Media Contact

Website: https://www.hansrobot.net/

Email: marketing@huayanrobotics.com | hansrobot_international@hanslaser.com

LinkedIn: https://www.linkedin.com/company/huayanrobotics

YouTube: https://www.youtube.com/@huayanrobotics

TESSAN Partners with One Tree Planted to Promote Global Reforestation Efforts

LOS ANGELES, April 29, 2025 /PRNewswire/ — TESSAN, a leading brand in home and travel charging solutions, has long been dedicated to integrating sustainable practices into its products and operations. In 2025, the company formalized this commitment by partnering with One Tree Planted, a renowned global environmental organization, to launch the “Charging the Future” initiative.

TESSAN Partners with One Tree Planted to Promote Global Reforestation Efforts
TESSAN Partners with One Tree Planted to Promote Global Reforestation Efforts

Tree planting isn’t a marketing tactic — it’s a responsibility we owe to the planet,” said Alex, Founder and CEO of TESSAN.”The devastating wildfires in Los Angeles didn’t just remind us of the urgent need for action—they also highlighted the power of rebuilding. At TESSAN, we believe that technology should not only empower daily life, but also contribute to restoring what’s been lost, and renewing the Earth for future generations.

Addressing Climate Change

Forests play a crucial role in mitigating climate change by absorbing approximately 2.6 billion tons of carbon dioxide annually—about one-third of global fossil fuel emissions. The Intergovernmental Panel on Climate Change (IPCC) emphasizes that restoring 900 million hectares of degraded forest land could absorb up to 30% of excess atmospheric carbon.

Promoting Biodiversity and Ecosystem Resilience

Forests are essential for biodiversity, supporting 80% of terrestrial species. For instance, the Amazon rainforest is home to 10% of Earth’s known biodiversity. However, unchecked deforestation in regions such as Brazil and Indonesia poses a significant threat to countless species. Rewilding initiatives in Kenya’s Mau Forest and mangrove restoration projects in Bangladesh demonstrate that reforestation not only protects endangered wildlife but also revitalizes ecosystems.

Fostering Economic and Social Impact

Reforestation initiatives also promote sustainable economic development. The World Resources Institute reports that integrating trees into farmland through agroforestry can increase crop yields by up to 300% in arid regions such as the Sahel in Africa. Since 2020, India’s rural employment guarantee program, which includes tree planting, has provided income for 50 million households.

From Roots to Forests: Where We Begin

Despite the recognized importance of trees, global deforestation continues at an alarming rate. It is crucial for governments, corporations, and individuals to invest in tree-planting initiatives. Simple actions, such as supporting local tree-planting campaigns or incorporating green spaces into urban planning, can have a profound impact on the environment and future generations.

Any significant action is inseparable from the contributions of each participant. TESSAN aims to incorporate the concept of environmental protection into all of its initiatives. Even a small effort can make a difference in preserving the Earth. Minor actions hold great potential. Allow a young sapling to grow into a forest. Join TESSAN’s mission to enhance the planet, and together, let us create a meaningful legacy for future generations.

About TESSAN

TESSAN is a trusted partner in charging solutions, committed to enhancing experiences both at home and during travel.  The brand offers a wide array of products, including multifunctional power strips, travel adapters, wall extenders, and smart home devices.  Supported by a robust R&D and production team, TESSAN develops innovative socket products for users worldwide.  With the trust of over 20 million users, TESSAN empowers their journeys from home to every destination, promoting environmentally conscious electricity usage.

For more information, visit www.tessan.com or the TESSAN Amazon store, and follow TESSAN on Facebook, Instagram, and YouTube.

CONTACT: Derien Lin, derien@tessan.com